MVIR:STO
Medivir AB
၁.၄၉ SEK
arrow_downward
-၀.၈၀%(-၀.၀၁၂) 1D
အောက် ၁၃, GMT+၂ ၁၇:၂၉:၅၇ · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MVIR...
Open
၁.၅၀ SEK
High
၁.၅၁ SEK
Low
၁.၄၇ SEK
Mkt. cap
၉၃.၀၁ ကုဋေ
Avg. vol.
၁.၄၆ သန်း
Volume
၆.၅၆ သိန်း
52-wk high
၂.၈၈ SEK
52-wk low
၀.၃၄ SEK
EPS
-၀.၃၇ SEK
Shares outstanding
၆၂.၄၂ ကုဋေ
No. of employees
၆
Open
၁.၅၀ SEK
High
၁.၅၁ SEK
Low
၁.၄၇ SEK
Mkt. cap
၉၃.၀၁ ကုဋေ
Avg. vol.
၁.၄၆ သန်း
Volume
၆.၅၆ သိန်း
52-wk high
၂.၈၈ SEK
52-wk low
၀.၃၄ SEK
EPS
-၀.၃၇ SEK
Shares outstanding
၆၂.၄၂ ကုဋေ
No. of employees
၆
News stories
From web sources and news partners
Stock Titan
·
ပြီးခဲ့သည့် ၃၆ မိနစ်
A one-year monitor leaves CN Healthy Food Tech (Nasdaq: UCFI) no cure period if listing standards lapse.
GlobeNewswire
·
ပြီးခဲ့သည့် ၁ နာရီ
Nasdaq Confirmed AGM Group Holdings Inc. Complies with The Nasdaq Listing Rules
Los Angeles Times
·
ပြီးခဲ့သည့် ၄၈ မိနစ်
Stocks edge back from their record following the first big batch of profit reports for the summer
Kitco
·
ပြီးခဲ့သည့် ၂၉ မိနစ်
Nasdaq ends down as chipmakers fall and bank earnings roll in
Profile
Medivir is a Swedish biotech company. Medivir focuses its research focus on oncology and particularly on innovative pharmaceuticals that meet substantial unmet medical needs. The pharmaceutical development work is conducted both in-house and through partnerships, usually with global pharmaceutical companies.
Medivir has a leading expertise in the design of protease inhibitors and in the science of nucleotides and nucleosides.
Medivir is listed on the Nasdaq Stockholm Mid Cap List.
In February 2020, Medivir announced that the company has signed a licensing agreement for Xerclear with Chinese company Shijiazhuang Yuanmai Biotechnology Co Ltd. The agreement gives SYB the right to register, manufacture and market the product in China. Wikipedia
About Medivir AB